Search for: "Novartis Pharmaceuticals Inc" Results 101 - 120 of 394
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Feb 2015, 1:44 am
  * "Fool's errand": no need to create your own brand if you can use someone else's Jeremy notes Speciality European Pharma Ltd v Doncaster Pharmaceuticals Group Ltd & Madaus GmbH [2015] EWCA Civ 54 [on which see earlier katpost here], a trade mark infringement decision of the Court of Appeal, England and Wales, on parallel importation and over-stickering of pharmaceutical products. [read post]
8 Feb 2015, 9:59 pm by Patent Docs
Roxane Laboratories Inc. 1:15-cv-00128; filed February 5, 2015 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
2 Feb 2015, 2:20 am
Kleemans (Freshfields Bruckhaus Deringer LLP, Amsterdam) reports on the Hague Court of Appeal’s summary ruling in a case between Novartis AG and Sun Pharmaceutical Industries BV. [read post]
4 Jan 2015, 9:21 pm by Patent Docs
Roxane Laboratories Inc. 1:14-cv-01508; filed December 23, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Roxane Laboratories Inc. [read post]
28 Dec 2014, 9:49 pm by Patent Docs
Par Pharmaceutical Inc. 1:14-cv-01494; filed December 18 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG • Defendant: Par Pharmaceutical Inc. [read post]
15 Dec 2014, 7:25 am
Last week was the busiest in the IPKat's history, with a total of 29 blogposts. [read post]
21 Oct 2014, 12:00 am
 Other recent pharmaceutical cases concerning inventive step There have been several cases in recent times where inventive step been determined in the context of a pharmaceutical invention. [read post]
22 Aug 2014, 9:22 am
Novartis Pharmaceutical Corp., 2013 WL 4648449 (M.D. [read post]
7 Aug 2014, 5:00 am
Novartis Pharmaceuticals Corp., 2014 WL 3735622 (E.D. [read post]
10 Jul 2014, 6:41 am by Schachtman
Indeed, we can see how manipulative the authors’ so-called transparency becomes in the context of evaluating causal claims in pharmaceutical approvals versus tort claims: “Very high standards of evidence are typically expected in order to infer causal relationships or to approve the marketing of new drugs. [read post]
30 Jun 2014, 4:23 am by Lawrence B. Ebert
Johnson & Johnson Medtronic Merck Millennium Pharmaceuticals, Inc. [read post]
29 Jun 2014, 9:21 pm by Patent Docs
Mylan Inc. et al. 1:14-cv-00777; filed June 19, 2014 in the District Court of Delaware • Plaintiffs: Novartis Pharmaceuticals Corp.; Novartis AG; Novartis Pharma AG; LTS Lohmann Therapie-Systeme AG • Defendants: Mylan Inc.; Mylan Pharmaceuticals Inc. [read post]
23 Jun 2014, 12:57 pm by Schachtman
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
22 May 2014, 5:00 am
Pfizer, Inc., 2000 WL 1099884, at *2 & n.1 (S.D.N.Y. [read post]
15 May 2014, 9:36 am by Matthew A. Reed
Novartis Pharmaceuticals Corp., --- F.3d ---, 2014 WL 1328182 (9th Cir. [read post]
19 Apr 2014, 8:50 am by Lawrence B. Ebert
Sanofi-Aventis, Annual Report (Form 20-F), at 61 (Mar. 7, 2008); Teva Pharmaceutical Industries Ltd., Annual Report (Form 20-F), at 20 (Mar. 31, 2001). [read post]
16 Apr 2014, 11:07 am by Pilar G. Kraman
Patents Nos. 6,335,031 and 6,316,023 at issue in the Novartis Pharmaceuticals Corp., et al. v. [read post]